3655 results for «214»
3655 results
How to achieve successful outcome in contemporary CTO PCI
15 May 2024 – From EuroPCR 2024
LAA closure - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, diabetes, obesity, and a history of pacemaker implantation in 2023, presented with retinal hemorrhage while on NACO for AF. Despite a CHA2DS2-VASC score of 5, anticoagulation was withdrawn. The operators implanted a Watchman device in the LAA via a venous right femoral...
Has the 2023 ESC-EACTS guideline review on left main changed my practice?
15 May 2024 – From EuroPCR 2024
Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...
Successful implementation of renal denervation in hypertension management (the hardest part is getting started)
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive guide on setting up a successful renal denervation program. It covers topics such as identifying the ideal patients for this therapy, integrating patient preferences in decision-making, the necessary workup process, and the procedural aspects of renal denervation. The session also features...
TAVI Hotline: new devices, new approaches
15 May 2024 – From EuroPCR 2024
Tailored techniques for left main bfurcation interventions
16 May 2024 – From EuroPCR 2024
This session explores various techniques and strategies for managing complex left main bifurcation lesions. It features case studies that demonstrate the use of hybrid PCI to reduce metal burden, the importance of IVUS guidance, the challenges of large dimension left main PCI, and the role of...
Challenges in acute coronary syndrome treatment
16 May 2024 – From EuroPCR 2024
This session delves into the challenges and emerging insights in the treatment of acute coronary syndrome (ACS). It features presentations and discussions on topics such as sex-based differences in treatment and outcomes in STEMI, the use of ticagrelor de-escalation strategy in CKD patients, the outcomes of...
TAV-in-TAV in complex situations
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on TAVI-in-TAVI procedures in complex situations. It covers various case presentations and discussions, including re-do TAVI with the risk of acute coronary obstruction, expanding possibilities in TAVR-in-TAVR with the mid-leaflet implantation technique, transcatheter valve-in-valve in self-expanding...
Contemporary TAVI cases: perspectives from three different continents
16 May 2024 – From EuroPCR 2024
This session provides perspectives from three different continents on the management of complex TAVI cases. It features case presentations and discussions on topics such as TAVR for the correction of aortic pseudoaneurysm, TAV-in-TAV intervention, and the management of aortic stenosis in patients with hypertrophic obstructive cardiomyopathy....
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference
28 Oct 2024
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)
03 Nov 2025
Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.
Author
Author
